Archive | January, 2013

Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005.

Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005. Frisher M, Crome I, Martino O, Croft P. Source Department of Medicines Management, Keele University, Staffordshire, UK. m.frisher@keele.ac.uk Abstract A recent systematic review concluded that cannabis use increases risk of psychotic outcomes independently of confounding and transient intoxication effects. […]

The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice.

2013 Jan;8(1):59-64. The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice. Vaseghi G, Rabbani M, Hajhashemi V. Author information Abstract Abrupt cessation of morphine leads to withdrawal signs and cognitive deficits. Endocannabinoid system is activated during withdrawal; therefore, the aim of the present study was to assess the effects of AM281, cannabinoid antagonist/inverse agonist, […]

Cannabinoid facilitation of fear extinction memory recall in humans

Neuropharmacology. Author manuscript; available in PMC Jan 1, 2014. Published in final edited form as: Neuropharmacology. Jan 2013; 64(1): 396–402.  Published online Jul 13, 2012. doi:  10.1016/j.neuropharm.2012.06.063 PMCID: PMC3445738 NIHMSID: NIHMS394102 Cannabinoid facilitation of fear extinction memory recall in humans Christine A. Rabinak,a Mike Angstadt,a Chandra S. Sripada,a James L. Abelson,a Israel Liberzon,a,b Mohammed R. Milad,c and  K. Luan Phana,b,d,e Author information ► Copyright and License information ► The […]